Standout Papers

The Antifungal Pipeline: Fosmanogepix, Ibrexafungerp, Olorofim, Opelconazole, and Rezafungin 2021 2026 2022 2024256
  1. The Antifungal Pipeline: Fosmanogepix, Ibrexafungerp, Olorofim, Opelconazole, and Rezafungin (2021)
    Martin Hoenigl, Rosanne Sprute et al. Drugs

Immediate Impact

3 from Science/Nature 59 standout
Sub-graph 1 of 21

Citing Papers

Global incidence and mortality of severe fungal disease
2024 Standout
Guide to Utilization of the Microbiology Laboratory for Diagnosis of Infectious Diseases: 2024 Update by the Infectious Diseases Society of America (IDSA) and the American Society for Microbiology (ASM)
2024 Standout
4 intermediate papers

Works of Juergen Prattes being referenced

Invasive aspergillosis in patients with underlying liver cirrhosis: a prospective cohort study
2017
Diagnostic performance of 1,3‐beta‐D‐glucan serum screening in patients receiving hematopoietic stem cell transplantation
2016
and 4 more

Author Peers

Author Last Decade Papers Cites
Juergen Prattes 1923 1650 281 77 2.2k
Jeffrey D. Jenks 1655 1284 149 50 2.0k
Philipp Koehler 1592 1149 212 61 1.9k
F Sánchez 1282 1416 281 80 2.4k
Lena Klingspor 2305 1956 242 54 2.9k
Stefan Zimmerli 1523 1256 128 68 2.4k
Silke Schelenz 2002 1514 298 69 2.7k
Takayoshi Tashiro 1509 1516 440 141 2.7k
Christopher D. Pfeiffer 1553 1373 153 43 1.9k
G. Just‐Nübling 1519 1362 172 40 1.8k
R. Grillot 1527 1167 184 75 2.1k

All Works

Loading papers...

Rankless by CCL
2026